Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer (TAPUR) TAPUR

What's the purpose of this trial?

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug.

This trial is currently open and accepting patients.


You may be able to join this trial if you:

The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.

Inclusion Criteria:

  • 12 years of age or older (*Restrictions apply. Not all therapies are available for patients <18)
  • Histologically-proven locally advanced or metastatic solid tumor, multiple myeloma or B cell non-Hodgkin lymphoma who is no longer benefiting from standard anti-cancer treatment or for whom, in the opinion of the treating physician, no such treatment is available or indicated
  • Performance status 0-2 (Per Eastern Cooperative Oncology Group (ECOG) criteria)
  • Patients must have acceptable organ function as defined below. However, as noted above, drug-specific inclusion/exclusion criteria specified in the protocol appendix for each agent will take precedence for this and all inclusion criteria:
    1. Absolute neutrophil count ≥ 1.5 x 106/µl
    2. Hemoglobin > 9.0 g/dl
    3. Platelets > 75,000/µl
    4. Total bilirubin < 2.0 mg/ dl, except in patients with Gilbert's Syndrome
    5. Aspartate aminotransferase (AST) serum glutamic-oxaloacetic transaminase (SGOT) and alanine aminotransferase (ALT) serum glutamic-pyruvic transaminase (SGPT) < 2.5 x institutional upper limit of normal (ULN) (or < 5 x ULN in patients with known hepatic metastases)
    6. Serum creatinine ≤ 1.5 × ULN or calculated or measured creatinine clearance ≥ 50 mL/min/1.73 m2
  • Patients must have disease that can be objectively measured by physicial or radiographic exam or evaluable disease (per RECIST v1.1 for solid tumor, Lugano criteria for non Hodgkin lymphoma or International Myeloma Working Group criteria for multiple myeloma), defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded for non-nodal lesions and short axis for nodal lesions) as ≥20 mm with conventional techniques or as ≥10 mm with spiral computed tomography (CT) scan, Magnetic Resonance Imaging (MRI), or a subcutaneous or superficial lesion that can be measured with calipers by clinical exam. For lymph nodes, the short axis must be ≥15 mm. Patients who have assessable disease by physical or radiographic examination but do not meet these definitions of measurable disease are eligible and will be considered to have evaluable disease. Patient's whose disease cannot be objectively measured by physical or radiographic examination (e.g., elevated serum tumor marker only, bone-only disease without an identifiable soft tissue component, or patients with only assessable non-measurable disease) are NOT eligible.
  • Results must be available from a genomic test or immunohistochemistry (IHC) test for protein expression performed in a Clinical Laboratory Improvement Amendments (CLIA)-certified and College of American Pathologists (CAP)-accredited or New York State accredited (for labs offering services to residents of NY) laboratory. Labs that have registered the test with the NIH Genetic Testing Registry or that provide a report that has been designated as optimized for TAPUR participation are preferred, but not required. The genomic or IHC test used to qualify a patient for participation in TAPUR may have been performed on any specimen of the patient's tumor obtained at any point during the patient's care at the discretion of the patient's treating physician. Genomic assays performed on cell-free DNA in plasma ("liquid biopsies") will also be acceptable if the genomic analysis is performed in a laboratory that meets the criteria described above.
  • Ability to understand and the willingness to sign a written informed consent/assent document.
  • Have a tumor genomic profile for which single agent treatment with one of the FDA approved targeted anti-cancer drugs included in this study has potential clinical benefit based on the criteria described in protocol.
  • For orally administered drugs, the patient must be able to swallow and tolerate oral medication and must have no known malabsorption syndrome.
  • Because of the risks of drug treatment to the developing fetus, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) for the duration of study participation, and for four months following completion of study therapy. Should a woman become pregnant or suspect she is pregnant while participating in this study or if she is the partner of a male participant in this study and becomes pregnant while he is participating in this study, she should inform her or her partner's treating physician immediately as well as her obstetrician. Female study patients who become pregnant must immediately discontinue treatment with any study therapy. Male patients should avoid impregnating a female partner. Male study patients, even if surgically sterilized, (i.e. post-vasectomy) must agree to one of the following: practice effective barrier contraception during the entire study treatment period and for a specified amount of time the last dose of study drug, or completely abstain from sexual intercourse.

Note: TAPUR does not explicitly exclude any type of solid tumor, but the patient must have measurable and evaluable disease per RECIST v1.1.

Exclusion Criteria:

  • Patients whose disease is not measurable or cannot be assessed by radiographic imaging or physical examination (e.g., elevated serum tumor marker only) are not eligible
  • Patients with primary brain tumors or leptomeningeal metastases are excluded.
  • Patients with previously treated brain metastases are eligible, provided that the patient has not experienced a seizure or had a clinically significant change in neurological status within the 3 months prior to registration. All patients with previously treated brain metastases must be clinically stable for at least 1 month after completion of treatment and off steroid treatment for one month prior to study enrollment.
  • Patients with known progressive brain metastases are eligible but additional eligibility criteria apply.

 

Note: there are additional exclusion criteria that may apply


Additional Trial Information

Phase 2

Enrollment: 3,641 patients (estimated)

View More

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.

Alabama

University of Alabama at Birmingham O'Neal Comprehensive Cancer Center

Birmingham, AL

Open and Accepting

Arizona

Cancer Treatment Centers of America - WRMC-Phoenix

Goodyear, AZ

Open and Accepting

California

Sutter Auburn Faith Hospital

Auburn, CA

Open and Accepting

Sutter Cancer Research Consortium - Alta Bates - Berkley

Berkeley, CA

Open and Accepting

Alta Bates Cancer Care Center

Berkeley, CA

Open and Accepting

Tower Hematology Oncology

Beverly Hills, CA

Open and Accepting

Mills Peninsula Medical Center

Burlingame, CA

Open and Accepting

Sutter Cancer Research Consortium - Fairfield

Fairfield, CA

Open and Accepting

Sutter Cancer Research Consortium - Fremont

Fremont, CA

Open and Accepting

Cedars-Sinai The Angeles Clinic and Research Institute

Los Angeles, CA

Open and Accepting

Sutter Gould Medical Foundation - Sutter Cancer Research Consortium

Modesto, CA

Open and Accepting

Sutter Cancer Research Consortium - Mountain View

Mountain View, CA

Open and Accepting

Kaiser Permanente - Oakland Medical Center

Oakland, CA

Open and Accepting

Palo Alto Medical Foundation - Sutter Cancer Research Consortium

Palo Alto, CA

Open and Accepting

The Angeles Clinic - Torrance Memorial Physician Network Cancer Care

Redondo Beach, CA

Open and Accepting

Kaiser Permanente - Roseville Medical Center

Roseville, CA

Open and Accepting

Sutter Health Medical Foundation - Roseville

Roseville, CA

Open and Accepting

Sutter General Hospital - Sacramento - Sutter Cancer Research Consortium

Sacramento, CA

Open and Accepting

Kaiser Permanente - Sacramento Medical Center

Sacramento, CA

Open and Accepting

Sutter Health California Pacific Medical Center (Webster)

San Francisco, CA

Open and Accepting

Kaiser Permanente - San Francisco Medical Center

San Francisco, CA

Open and Accepting

Sutter Health California Pacific Medical Center (California St)

San Francisco, CA

Open and Accepting

San Francisco Oncology Associates

San Francisco, CA

Open and Accepting

Kaiser Permanente - San Jose Medical Center

San Jose, CA

Open and Accepting

Kaiser Permanente - San Leandro Medical Center

San Leandro, CA

Open and Accepting

Sutter Cancer Research Consortium - San Mateo

San Mateo, CA

Open and Accepting

Kaiser Permanente - Santa Clara Medical Center

Santa Clara, CA

Open and Accepting

Sutter Cancer Research Consortium - Santa Cruz

Santa Cruz, CA

Open and Accepting

Sutter Cancer Research Consortium - Santa Rosa Suite 300

Santa Rosa, CA

Open and Accepting

Sutter Cancer Research Consortium - Sutter Pacific Medical Foundation

Santa Rosa, CA

Open and Accepting

Kaiser Permanente (South San Francisco Medical Center)

South San Francisco, CA

Open and Accepting

Sutter Cancer Research Consortium - Sunnyvale Center

Sunnyvale, CA

Open and Accepting

Kaiser Permanente - Vallejo Medical Center

Vallejo, CA

Open and Accepting

Sutter Solano Cancer Center

Vallejo, CA

Open and Accepting

Kaiser Permanente (Walnut Creek Medical Center)

Walnut Creek, CA

Open and Accepting

Connecticut

Saint Vincent’s Medical Center (SVMC) - Hartford Healthcare

Bridgeport, CT

Open and Accepting

Hartford Hospital

Hartford, CT

Open and Accepting

Midstate Medical Center

Meriden, CT

Open and Accepting

The Hartford HealthCare Cancer Institute The Hospital of Central Connecticut

New Britain, CT

Open and Accepting

William W. Backus Hospital

Norwich, CT

Open and Accepting

Charlotte Hungerford Hospital Center for Cancer Care - Hartford Healthcare

Torrington, CT

Open and Accepting

Windham Hospital

Windham, CT

Open and Accepting

Florida

Sylvester Comprehensive Cancer Center University of Miami - Aventura

Aventura, FL

Open and Accepting

Sylvester Comprehensive Cancer Center University of Miami

Coral Gables, FL

Open and Accepting

Sylvester Comprehensive Cancer Center University of Miami

Deerfield Beach, FL

Open and Accepting

Holy Cross Hospital

Fort Lauderdale, FL

Open and Accepting

Shands Hospital University of Florida Health

Gainesville, FL

Open and Accepting

Sylvester Comprehensive Cancer Center University of Miami - Kendall

Miami, FL

Open and Accepting

Sarah Cannon Research Institute FCS South - Naples (4th Avenue)

Naples, FL

Open and Accepting

Florida Cancer Specialists - North - Trinity

New Port Richey, FL

Open and Accepting

University of Miami - Sylvester Comprehensive Cancer Center - Plantation

Plantation, FL

Open and Accepting

Georgia

Winship Cancer Institute Emory University

Atlanta, GA

Open and Accepting

Emory University Winship Cancer Institute - St. Joseph

Atlanta, GA

Open and Accepting

Emory University Winship Cancer Institute - Midtown

Atlanta, GA

Open and Accepting

Emory University Winship Cancer Institute - Johns Creek

Johns Creek, GA

Open and Accepting

Lewis Cancer and Research Pavilion - Summit Cancer Care Suite 300

Savannah, GA

Open and Accepting

Hawaii

Queen's Medical Center

Honolulu, HI

Open and Accepting

Illinois

Indiana

Community MD Anderson Cancer Center - North Community Hospital East

Indianapolis, IN

Open and Accepting

Community Health Network - East

Indianapolis, IN

Open and Accepting

Community Health Network - South

Indianapolis, IN

Open and Accepting

Community Health Network - Kokomo

Kokomo, IN

Open and Accepting

Maine

Harold Alfond Center for Cancer Care MaineGeneral Medical Center

Augusta, ME

Open and Accepting

Eastern Maine Medical Center

Bangor, ME

Open and Accepting

Waldo County General Hospital MaineHealth

Belfast, ME

Open and Accepting

SMHC Cancer Care - Biddeford MaineHealth

Biddeford, ME

Open and Accepting

Lafayette Family Cancer Institute Northern Light Health

Brewer, ME

Open and Accepting

SMHC Cancer Care - Brunswick MaineHealth

Brunswick, ME

Open and Accepting

New England Cancer Specialists - Kennebunk

Kennebunk, ME

Open and Accepting

York Hospital Oncology & Infusion Care York - Kittery

Kittery, ME

Open and Accepting

Stephens Memorial Hospital MaineHealth

Norway, ME

Open and Accepting

Penobscot Bay Medical Center

Rockport, ME

Open and Accepting

SMHC Cancer Care - Sanford MaineHealth

Sanford, ME

Open and Accepting

Maine Children's Cancer Program

Scarborough, ME

Open and Accepting

New England Cancer Specialists

Scarborough, ME

Open and Accepting

Maine Medical Partners Women's Health - Scarborough

Scarborough, ME

Open and Accepting

MaineHealth Cancer Care - South Portland

South Portland, ME

Open and Accepting

New England Cancer Specialists - Topsham

Topsham, ME

Open and Accepting

York Hospital Oncology & Infusion Care - Wells

Wells, ME

Open and Accepting

York Hospital Cancer Care

York, ME

Open and Accepting

Michigan

University of Michigan Comprehensive Cancer Center Rogel Cancer Center

Ann Arbor, MI

Open and Accepting

Bronson Battle Creek Cancer Care Center

Battle Creek, MI

Open and Accepting

Chelsea Hospital Michigan Cancer Research Consortium

Chelsea, MI

Open and Accepting

Great Lakes Cancer Management Specialists (Doctors Park)

East China, MI

Open and Accepting

Genesys Hurley Cancer Institute

Flint, MI

Open and Accepting

The Cancer & Hematology Centers

Flint, MI

Open and Accepting

Genesee Hematology Oncology, PC - Michigan Cancer Research Consortium

Flint, MI

Open and Accepting

Cancer Research Consortium of West Michigan - Spectrum Health Butterworth

Grand Rapids, MI

Open and Accepting

Mercy Health Saint Mary's

Grand Rapids, MI

Open and Accepting

Van Elslander Cancer Center

Grosse Pointe Woods, MI

Open and Accepting

Academic Hematology Oncology Specialists Ascension St. John Hospital

Grosse Pointe Woods, MI

Open and Accepting

Cancer Research Consortium of West Michigan - Bronson Cancer Care - Kalamazoo

Kalamazoo, MI

Open and Accepting

West Michigan Cancer Center

Kalamazoo, MI

Open and Accepting

Sparrow Hospital

Lansing, MI

Open and Accepting

Michigan Cancer Research Consortium - Trinity Health Livonia Hospital

Livonia, MI

Open and Accepting

Great Lakes Cancer Management Specialists (Macomb Medical Campus)

Macomb, MI

Open and Accepting

Cancer Research Consortium of West Michigan - Mercy Health Mercy Campus

Muskegon, MI

Open and Accepting

Michigan Cancer Research Consortium - Trinity Health Oakland Hospital

Pontiac, MI

Open and Accepting

Spectrum Health Reed City Hospital

Reed City, MI

Open and Accepting

Ascension St. Mary's Hospital

Saginaw, MI

Open and Accepting

Oncology Hematology Associates of Saginaw Valley PC

Saginaw, MI

Open and Accepting

Cancer Research Consortium of West Michigan - Lakeland HealthCare

St. Joseph, MI

Open and Accepting

Ascension Saint Joseph Hospital

Tawas City, MI

Open and Accepting

Munson Medical Center

Traverse City, MI

Open and Accepting

Michigan Cancer Research Consortium - Macomb Professional Building

Warren, MI

Open and Accepting

Michigan Cancer Research Consortium - Advanced Breast Care Center PLLC

Warren, MI

Open and Accepting

Michigan Breast Specialists-Warren

Warren, MI

Open and Accepting

Ascension St. Mary's Hospital Seton Cancer Institute

West Branch, MI

Open and Accepting

Metro Health Hospital

Wyoming, MI

Open and Accepting

Trinity Health Ann Arbor Hospital

Ypsilanti, MI

Open and Accepting

Nebraska

University of Nebraska Medical Center - Bellevue

Bellevue, NE

Open and Accepting

Nebraska Medicine (Village Pointe)

Omaha, NE

Open and Accepting

New Hampshire

New Hampshire Oncology-Hematology (Concord)

Concord, NH

Open and Accepting

New Hampshire Oncology-Hematology at Solinsky Center for Cancer Care The Elliot

Manchester, NH

Open and Accepting

New Mexico

Presbyterian Kaseman Hospital - New Mexico Cancer Research Alliance (NMCRA)

Albuquerque, NM

Open and Accepting

University of New Mexico Comprehensive Cancer Center

Albuquerque, NM

Open and Accepting

Lovelace Medical Center (St. Joseph Square)

Albuquerque, NM

Open and Accepting

Memorial Medical Center - New Mexico Cancer Research Alliance (NMCRA)

Las Cruces, NM

Open and Accepting

New York

Northwell Health Center for Advanced Medicine Monter Cancer Center

Lake Success, NY

Open and Accepting

Northwell Health Manhattan Eye, Ear, & Throat Hospital

Manhattan, NY

Open and Accepting

Staten Island University Hospital

New York, NY

Open and Accepting

Steven and Alexandra Cohen Children's Medical Center Northwell Health

Queens, NY

Open and Accepting

Phelps Hospital Northwell Health

Sleepy Hollow, NY

Open and Accepting

North Carolina

UNC Lineberger Comprehensive Cancer Center University of North Carolina

Chapel Hill, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - Charlotte (Main) Atrium Health

Charlotte, NC

Open and Accepting

Atrium Health's Levine Cancer Institute (Pineville)

Charlotte, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - University

Charlotte, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - Ballantyne

Charlotte, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - Mallard Creek

Charlotte, NC

Open and Accepting

Atrium Health Levine Cancer Institute - Cabarrus

Concord, NC

Open and Accepting

Atrium Health's Levine Cancer Institute / Blue Ridge - Valdese Annex

Connelly Springs, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - Blue Ridge - Rutherford College

Connelly Springs, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - Rutherford

Forest City, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - Gaston

Gastonia, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - Lincolnton

Lincolnton, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - Union West

Matthews, NC

Open and Accepting

Atrium Health's Levine Cancer Institute - Blue Ridge - Morganton

Morganton, NC

Open and Accepting

North Dakota

Sanford Bismarck Medical Center Bismarck Cancer Center

Bismarck, ND

Open and Accepting

Sanford Medical Center - Broadway

Fargo, ND

Open and Accepting

Ohio

Soin Medical Center Kettering Health Cancer Center

Beavercreek, OH

Open and Accepting

The Fort Hamilton Hospital - Gebhart Cancer Center - Kettering Health

Hamilton, OH

Open and Accepting

Kettering Cancer Care

Kettering, OH

Open and Accepting

Kettering Health - Kettering Cancer Care at Troy

Troy, OH

Open and Accepting

University of Cincinnati Medical Center - West Chester Hospital

West Chester Township, OH

Open and Accepting

Oregon

Providence Oncology and Hematology - Southeast

Clackamas, OR

Open and Accepting

Providence Oncology and Hematology - Newberg

Newberg, OR

Open and Accepting

Pennsylvania

Lehigh Valley Health Network Cancer Institute

Allentown, PA

Open and Accepting

Lehigh Valley Hospital - Muhlenberg

Bethlehem, PA

Open and Accepting

Pocono Medical Center

East Stroudsburg, PA

Open and Accepting

Michigan Cancer Research Consortium - Lehigh Valley Hospital-Hazleton

Hazleton, PA

Open and Accepting

Fox Chase Cancer Center Temple Health

Philadelphia, PA

Open and Accepting

South Carolina

St. Joseph’s/Candler Bluffton Buckwalter Place

Bluffton, SC

Open and Accepting

South Carolina Cancer Specialists - Lewis Cancer and Research Pavilion

Hilton Head Island, SC

Open and Accepting

Atrium Health's Levine Cancer Institute - Rock Hill

Rock Hill, SC

Open and Accepting

South Dakota

Sanford Cancer Center

Sioux Falls, SD

Open and Accepting

Tennessee

Sarah Cannon Tennessee Oncology- Nashville -Dickson

Dickson, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville - Franklin

Franklin, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville - Gallatin

Gallatin, TN

Open and Accepting

Sarah Cannon Research Institute TO - Hendersonville

Hendersonville, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville - Lebanon

Lebanon, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville - Murfreesboro

Murfreesboro, TN

Open and Accepting

Sarah Cannon Research Institute TO - Hermitage

Nashville, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville (Dickerson Rd)

Nashville, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville (Hayes St.)

Nashville, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville (Wallace Rd)

Nashville, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville - (Harding Rd.)

Nashville, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville - Shelbyville

Shelbyville, TN

Open and Accepting

Sarah Cannon Tennessee Oncology- Nashville - Smyrna

Smyrna, TN

Open and Accepting

Texas

The University of Texas MD Anderson Cancer Center - Woodlands

Conroe, TX

Open and Accepting

MD Anderson Cancer Center The University of Texas

Houston, TX

Open and Accepting

The University of Texas MD Anderson Cancer Center - Katy

Houston, TX

Open and Accepting

The University of Texas MD Anderson Cancer Center - Bay Area

Houston, TX

Open and Accepting

The University of Texas MD Anderson Cancer Center - Sugar Land

Sugar Land, TX

Open and Accepting

Utah

Intermountain Healthcare - Dixie Regional Medical Center - East Campus

Salt Lake City, UT

Open and Accepting

Intermountain Healthcare - Dixie Regional Medical Center-River Road Campus

St. George, UT

Open and Accepting

Virginia

IMG Oncology Oncology GYN

Annandale, VA

Open and Accepting

Inova Schar Cancer Institute Inova Fairfax Hospital

Fairfax, VA

Open and Accepting

Inova Fair Oaks Hospital

Fairfax, VA

Open and Accepting

Inova Fairfax Medical Hospital Inova Schar Cancer Institute

Falls Church, VA

Open and Accepting

Washington

Swedish Cancer Institute Swedish Edmonds Campus

Edmonds, WA

Open and Accepting

Swedish Cancer Institute

Issaquah, WA

Open and Accepting

Swedish Cancer Institute - Cherry Hill Campus

Seattle, WA

Open and Accepting

Gynecologic Oncology and Pelvic Surgery Clinic - First Hill

Seattle, WA

Open and Accepting

Swedish - First Hill Campus

Seattle, WA

Open and Accepting

Swedish Medical Center (Ballard Campus)

Seattle, WA

Open and Accepting

Wisconsin

Aurora Cancer Care - Burlington

Burlington, WI

Open and Accepting

Aurora Health Care - Germantown Health Center - Advocate Aurora Healthcare

Germantown, WI

Open and Accepting

Aurora Cancer Care (Grafton)

Grafton, WI

Open and Accepting

Aurora BayCare Medical Center

Green Bay, WI

Open and Accepting

Aurora Cancer Care - Kenosha South

Kenosha, WI

Open and Accepting

Aurora Cancer Care (Marinette) Aurora Health

Marinette, WI

Open and Accepting

Aurora St. Luke's Medical Center

Milwaukee, WI

Open and Accepting

Aurora Sinai Medical Center - Advocate Aurora Healthcare

Milwaukee, WI

Open and Accepting

Aurora Cancer Care

Milwaukee, WI

Open and Accepting

Aurora Cancer Care - Racine

Mount Pleasant, WI

Open and Accepting

Vince Lombardi Cancer Clinic - Oshkosh

Oshkosh, WI

Open and Accepting

Vince Lombardi Cancer Clinic - Sheboygan

Sheboygan, WI

Open and Accepting

Aurora Medical Center in Summit

Summit, WI

Open and Accepting

Vince Lombardi Cancer Clinic

Two Rivers, WI

Open and Accepting

Aurora Cancer Care - Milwaukee West - Advocate Aurora Healthcare

Wauwatosa, WI

Open and Accepting

Aurora West Allis Medical Center

West Allis, WI

Open and Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message